Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

Rituximab with or without a conventional maintenance agent in the treatment of relapsing granulomatosis with polyangiitis (Wegener's): a retrospective single-center study.

Azar L, Springer J, Langford CA, Hoffman GS.

Arthritis Rheumatol. 2014 Oct;66(10):2862-70. doi: 10.1002/art.38744.

PMID:
24943239
[PubMed - indexed for MEDLINE]
2.

Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients.

Calich AL, Puéchal X, Pugnet G, London J, Terrier B, Charles P, Mouthon L, Guillevin L; French Vasculitis Study Group.

J Autoimmun. 2014 May;50:135-41. doi: 10.1016/j.jaut.2014.03.002. Epub 2014 Apr 2.

PMID:
24703438
[PubMed - indexed for MEDLINE]
3.

Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center.

Cartin-Ceba R, Golbin JM, Keogh KA, Peikert T, Sánchez-Menéndez M, Ytterberg SR, Fervenza FC, Specks U.

Arthritis Rheum. 2012 Nov;64(11):3770-8. doi: 10.1002/art.34584.

PMID:
22730028
[PubMed - indexed for MEDLINE]
Free Article
4.

Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations.

Holle JU, Dubrau C, Herlyn K, Heller M, Ambrosch P, Noelle B, Reinhold-Keller E, Gross WL.

Ann Rheum Dis. 2012 Mar;71(3):327-33. doi: 10.1136/ard.2011.153601. Epub 2011 Oct 21.

PMID:
22021864
[PubMed - indexed for MEDLINE]
5.

Granulomatosis with polyangiitis (Wegener's): impact of maintenance therapy duration.

Springer J, Nutter B, Langford CA, Hoffman GS, Villa-Forte A.

Medicine (Baltimore). 2014 Mar;93(2):82-90. doi: 10.1097/MD.0000000000000020.

PMID:
24646464
[PubMed - indexed for MEDLINE]
6.

Efficacy and safety of rituximab as maintenance therapy for relapsing granulomatosis with polyangiitis—a case series.

Knight A, Hallenberg H, Baecklund E.

Clin Rheumatol. 2014 Jun;33(6):841-8.

PMID:
23959445
[PubMed - in process]
Free PMC Article
7.

Effectiveness of rituximab for the otolaryngologic manifestations of granulomatosis with polyangiitis (Wegener's).

Lally L, Lebovics RS, Huang WT, Spiera RF.

Arthritis Care Res (Hoboken). 2014 Sep;66(9):1403-9.

PMID:
25299002
[PubMed - indexed for MEDLINE]
8.

Long-term efficacy and safety of pre-emptive maintenance therapy with rituximab in granulomatosis with polyangiitis: results from a single centre.

Besada E, Koldingsnes W, Nossent JC.

Rheumatology (Oxford). 2013 Nov;52(11):2041-7. doi: 10.1093/rheumatology/ket257. Epub 2013 Aug 11.

PMID:
23934313
[PubMed - indexed for MEDLINE]
9.

Treatment of antineutrophil cytoplasmic antibody-associated vasculitis with rituximab.

Cartin-Ceba R, Fervenza FC, Specks U.

Curr Opin Rheumatol. 2012 Jan;24(1):15-23. doi: 10.1097/BOR.0b013e32834d5730. Review.

PMID:
22089095
[PubMed - indexed for MEDLINE]
10.

Rituximab in the treatment of refractory or relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).

Thiel J, Hässler F, Salzer U, Voll RE, Venhoff N.

Arthritis Res Ther. 2013 Sep 24;15(5):R133. doi: 10.1186/ar4313.

PMID:
24286362
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Rituximab maintenance therapy for granulomatosis with polyangiitis and microscopic polyangiitis.

Roubaud-Baudron C, Pagnoux C, Méaux-Ruault N, Grasland A, Zoulim A, LE Guen J, Prud'homme A, Bienvenu B, de Menthon M, Camps S, LE Guern V, Aouba A, Cohen P, Mouthon L, Guillevin L; French Vasculitis Study Group.

J Rheumatol. 2012 Jan;39(1):125-30. doi: 10.3899/jrheum.110143. Epub 2011 Nov 15.

PMID:
22089465
[PubMed - indexed for MEDLINE]
12.

Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.

Pagnoux C, Mahr A, Hamidou MA, Boffa JJ, Ruivard M, Ducroix JP, Kyndt X, Lifermann F, Papo T, Lambert M, Le Noach J, Khellaf M, Merrien D, Puéchal X, Vinzio S, Cohen P, Mouthon L, Cordier JF, Guillevin L; French Vasculitis Study Group.

N Engl J Med. 2008 Dec 25;359(26):2790-803. doi: 10.1056/NEJMoa0802311.

PMID:
19109574
[PubMed - indexed for MEDLINE]
Free Article
13.

Serum immunoglobulin levels and risk factors for hypogammaglobulinaemia during long-term maintenance therapy with rituximab in patients with granulomatosis with polyangiitis.

Besada E, Koldingsnes W, Nossent JC.

Rheumatology (Oxford). 2014 Oct;53(10):1818-24. doi: 10.1093/rheumatology/keu194. Epub 2014 May 15.

PMID:
24831059
[PubMed - in process]
14.

Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis.

Alberici F, Smith RM, Jones RB, Roberts DM, Willcocks LC, Chaudhry A, Smith KG, Jayne DR.

Rheumatology (Oxford). 2014 Dec 3. pii: keu452. [Epub ahead of print]

PMID:
25477054
[PubMed - as supplied by publisher]
15.

Rituximab Versus Cyclophosphamide for ANCA-Associated Vasculitis with Renal Involvement.

Geetha D, Specks U, Stone JH, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Fessler BJ, Ding L, Tchao NK, Ikle D, Jepson B, Brunetta P, Fervenza FC; for the Rituximab for ANCA-Associated Vasculitis Immune Tolerance Network Research Group.

J Am Soc Nephrol. 2014 Nov 7. pii: ASN.2014010046. [Epub ahead of print]

PMID:
25381429
[PubMed - as supplied by publisher]
16.

Update on the treatment of granulomatosis with polyangiitis (Wegener's).

Langford CA.

Curr Treat Options Cardiovasc Med. 2012 Apr;14(2):164-76. doi: 10.1007/s11936-012-0165-x.

PMID:
22270373
[PubMed]
17.

Etanercept plus standard therapy for Wegener's granulomatosis.

Wegener's Granulomatosis Etanercept Trial (WGET) Research Group.

N Engl J Med. 2005 Jan 27;352(4):351-61.

PMID:
15673801
[PubMed - indexed for MEDLINE]
Free Article
18.

An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegener's).

Langford CA, Monach PA, Specks U, Seo P, Cuthbertson D, McAlear CA, Ytterberg SR, Hoffman GS, Krischer JP, Merkel PA; Vasculitis Clinical Research Consortium.

Ann Rheum Dis. 2014 Jul;73(7):1376-9. doi: 10.1136/annrheumdis-2013-204164. Epub 2013 Dec 9.

PMID:
24323392
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitis.

Miloslavsky EM, Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Tchao NK, Viviano L, Ding L, Sejismundo LP, Mieras K, Iklé D, Jepson B, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh K, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Stone JH; Rituximab in ANCA-Associated Vasculitis-Immune Tolerance Network Research Group.

Arthritis Rheum. 2013 Sep;65(9):2441-9. doi: 10.1002/art.38044.

PMID:
23754238
[PubMed - indexed for MEDLINE]
Free Article
20.

Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patients.

Charles P, Néel A, Tieulié N, Hot A, Pugnet G, Decaux O, Marie I, Khellaf M, Kahn JE, Karras A, Ziza JM, Deligny C, Tchérakian C, Guillevin L; French Vasculitis Study Group.

Rheumatology (Oxford). 2014 Mar;53(3):532-9. doi: 10.1093/rheumatology/ket381. Epub 2013 Nov 26.

PMID:
24282319
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk